On Aug. 12, 2020, Pfizer and BioNTech announced that preliminary, peer-reviewed data from their BNT162 mRNA-based vaccine development…
On Aug. 5, 2020, BioNTech and Shanghai Fosun Pharmaceutical announced that the first 72 participants had been dosed…
On Aug. 5, 2020, Pfizer Canada and BioNTech announced an agreement with the Government of Canada to supply…
On Aug. 5, 2020, Pfizer and Shanghai Fosun Pharmaceutica announced that the first 72 participants had been dosed…
On Jul. 31, 2020, Pfizer and BioNTech announced an agreement with the Ministry of Health, Labour and Welfare…
On Jul. 31, 2020, Sanofi and GSK announced advanced discussions, with the European Commission for the supply of…
On Jul. 22, 2020, Pfizer and BioNTech announced execution of an agreement with the U.S. Department of Health…
On Jul. 20, 2020, Pfizer and BioNTech announced an agreement with the United Kingdom to supply 30 million…
On Jul. 20, 2020, BioNTech and Pfizer announced initial data from their ongoing German Phase 1/2, open-label, non-randomized,…
On Jul. 13, 2020, Pfizer and BioNTech announced that two of the companiesﾒ four investigational vaccine candidates from…
On Jul. 6, 2020, the European Investment Bank (EIB) and CureVac announced they had entered into a $75…
On Jul. 1, 2020, Pfizer and BioNTech announced preliminary data from the most advanced of four investigational vaccine…
On Jun. 17, 2020, CureVac announced that the German Health Authority Paul-Ehrlich-Institute and the Belgian Federal Agency for…
On Jun. 15, 2020, the German Federal Minister for Economic Affairs and Energy, Peter Altmaier, and Dietmar Hopp,…
On Jun. 15, 2020, Immunic announced dosing of the first patients in its phase 2, CALVID-1 clinical trial…
On Jun. 13, 2020, AstraZeneca announced an agreement with Europeﾒs Inclusive Vaccines Alliance (IVA), spearheaded by Germany, France,…
On Jun. 1, 2020, U.S. Dept. of Defense announced it had begun an effort to collect 8,000 donated…
On May 26, 2020, researchers at the Max Planck Institute for Evolutionary Anthropology in Germany and the Karolinska…
On May 13, 2020, Immunic announced it had received first regulatory approval from Germany’s BfArM to initiate a…
On May 5, 2020, Pfizer and BioNTech announced the first participants have been dosed in the U.S. in…
On Apr. 23, 2020, CHF Solutions announced that it had shipped the first commercial orders of its next…
On Apr. 22, 2020, BioNTech and Pfizer announced that the German regulatory authority, the Paul-Ehrlich-Institut, has approved the…
On Apr. 17, 2020, after promising COVID-19 treatments in Germany, France, Italy, Spain and the U.S,, ExThera Medical’s…
On Apr. 9, 2020, Pfizer and BioNTech disclosed additional details of their collaboration to advance candidates from BioNTech’s…
On Mar. 31, 2020, Chembio Diagnostics announced the U.S. launch of the rapid DPP COVID-19 serological point-of-care test…
On Mar. 30, 2020, Bayer announced it had made available more than 40 virus diagnostics devices from its…
On Mar. 24, 2020, Partner Therapeutics that Leukine (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim…
On Mar. 17, 2020, Pfizer and BioNTech SE announced the companies have agreed to a letter of intent…
On Mar. 15, 2020, Fosun Pharma and BioNTech announced a strategic development and commercialization collaboration to advance BioNTech’s…
On Mar. 5, 2020, Hologic announced a molecular assay for detecting the novel coronavirus SARS-CoV-2 (previously 2019-nCoV) on…